Results 181 to 190 of about 8,788 (204)

Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance

EBioMedicine, 2023
Abdullah, Syed Muhammad Umer, Kelvin Kai-Wang To   +1 more
exaly  

Nifedipine/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Nirmatrelvir/ritonavir use in pregnant women with SARS-CoV-2 Omicron infection: a target trial emulation

Nature Medicine, 2023
Carlos Wong, Kristy Tsz Kwan Lau, Gabriel Leung   +2 more
exaly  

Characterization of Virologic Rebound Following Nirmatrelvir-Ritonavir Treatment for Coronavirus Disease 2019 (COVID-19)

Clinical Infectious Diseases, 2023
Julie Boucau, Rockib Uddin, James Regan
exaly  

Structural basis for the in vitro efficacy of nirmatrelvir against SARS-CoV-2 variants

Journal of Biological Chemistry, 2022
Samantha Greasley, Stephen Noell, Olga Plotnikova   +2 more
exaly  

Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection

Journal of Pharmaceutical Analysis, 2023
Wujun Chen
exaly  

Nirmatrelvir and ritonavir

Clinical Therapeutics
openaire   +2 more sources

Dexamethasone/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source

Nirmatrelvir–Ritonavir and Viral Load Rebound in Covid-19

New England Journal of Medicine, 2022
exaly  

Carfilzomib/nirmatrelvir+ritonavir

Reactions Weekly, 2023
openaire   +1 more source